title: Blood-pool enhancement with SH U 508 A. Results of phase II clinical trials.
authors.affiliation: Clinical Development Diagnostics, Schering AG, Berlin, Germany.
authors.forename: R
authors.initials: R
authors.lastname: Schlief
authors.forename: R
authors.initials: R
authors.lastname: Schürmann
authors.forename: H P
authors.initials: HP
authors.lastname: Niendorf
mesh_terms: D003287:Contrast Media / Q000008:administration & dosage / Q000009:adverse effects; D004341:Drug Evaluation; D004361:Drug Tolerance; D004452:Echocardiography; D005690:Galactose / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans
chemical_list: D003287:Contrast Media; D005690:Galactose